ArticleCancer letters2024

Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma.

Julianna Korns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.